Home
Conditions
Lymphoma, T-Cell

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 106 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Recruiting

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

NCT03922724

Conditions: Autoimmune Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

National Marrow Donor Program Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

NCT01087333

Conditions: Adult T Cell Lymphoma (ATL), Anemia, Anemia, Hemolytic, +39 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

NCT07730515

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

NCT04045470

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

NCT06072131

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: University of California, San Francisco Fresno Clovis, California, United States

University of California, Los Angeles Hem/ Onc Clinical Research Unit, Suite 600 Santa Monica, California, United States

University of Colorado School of Medicine Aurora, Colorado, United States

Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute Pembroke Pines, Florida, United States

View all 69 locations

View Trial Details

Recruiting

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

NCT06176690

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type, +17 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

NCT07055477

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, +23 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

NCT06207812

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

NCT04288726

Conditions: Classical Hodgkin Lymphoma, Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Hemic and Lymphatic Diseases, +11 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

NCT06580002

Conditions: Adnexal Diseases, Blood Protein Disorders, Brain Cancer, +104 more
Locations: Chao Family Comprehensive Cancer Center, University of California Irvine Orange, California, United States

View Trial Details

Lymphoma, T-Cell

Lymphoma, T-Cell trial results

Related conditions